Retatrutide is classified as a triple glucagon hormone receptor agonist (GLP-1, GIP, and GCGR receptors), making it more effective for body fat mass reduction than its predecessor Semaglutide by targeting further receptors
A provider will evaluate: medical history metabolic markers weight management goals current medications lifestyle factors Based on this evaluation, providers can determine which therapies align best with your health needs
In patients in whom development of renal dysfunction is anticipated, particularly in elderly patients, renal function should be assessed more frequently and Janumet discontinued if evidence of renal impairment is present
These programs often work by partnering with pharmacies to reduce prescription medication prices
this page does not establish a stability window
We highly recommend using all three products in the Natural GLP-1 Activation Protocol daily for optimal and consistent results